Concepedia

Konstantina Grosios

KG

Statistics

Publications

14

Citations

1.2K

H-Index

13

Active since

1999

Affiliations

Novartis (Switzerland)(Current)

University of Leeds

Novartis Institutes for BioMedical Research

St James's University Hospital

University of Bradford

Konstantina Grosios is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and oncology.

Publications per year

1999–2021

14

Publications

14

AEE788

Peter Traxler, Peter R. Allegrini, Ralf Brandt et al. · Cancer Research · 2004 · 318 citations

, , +17

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

Konstantina Grosios, S E Holwell, Andrew McGown et al. · British Journal of Cancer · 1999 · 213 citations · Full text

, , +9

AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer

D. Mark Hickinson, Teresa Klinowska, Georgina Speake et al. · Clinical Cancer Research · 2010 · 120 citations

, , +17

Overview of healthcare in the UK

Konstantina Grosios, Peter B. Gahan, Jane Burbidge · The EPMA Journal · 2010 · 113 citations · Full text

, , +12

The RET Kinase Inhibitor NVP-AST487 Blocks Growth and Calcitonin Gene Expression through Distinct Mechanisms in Medullary Thyroid Cancer Cells

Nagako Akeno-Stuart, Michelle Croyle, Jeffrey A. Knauf et al. · Cancer Research · 2007 · 112 citations

, , +16

1–5 of 14